65 /100
HIGH RISK
Score updated May 30, 2026

CURX — Curanex Pharmaceuticals Inc Dilution Risk Tracker

Track CURX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CURX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
62
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split 70%
• 50-day avg $0.41 below $1 exchange minimum
• Only 3 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 2.6 months cash remaining
📉 Score Deterioration 50%
• Score rose 38 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔔 Track CURX — Get forecast alerts →

💹 Market Data

Market Cap$9.43M
Shares Outstanding28.34M
Float8.91M
Cash$108.9K
Debt$476.5K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 48.6% shares (2025Q4 vs prior)
11 institutional holders · 425.1K shares
#1 CITADEL ADVISORS LLC 104.3K shares
#2 DRW Securities, LLC 71.6K shares
#3 TWO SIGMA INVESTMENTS, LP 61.1K shares
+ 8 more holders Sign up free to view →

📉 Short Interest

Short Interest37.3K
Days to Cover1.0
% of Float0.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track CURX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CURX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CURX
📊 CURX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CURX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.